Thiopurine treatment of inflammatory bowel disease is linked to a risk for lymphoproliferative disorders, according to the results of a prospective observational cohort study reported online in the October 19 issue of The Lancet.
Thiopurine treatment of inflammatory bowel disease linked to risk for lymphoproliferative disorders